Citigroup »

Bridgebio Oncology Therapeut shares owned by Citigroup

Quarter-by-quarter ownership of Bridgebio Oncology Therapeut (BBOT) shares owned by Citigroup from 13F filings

Historical chart of Citigroup investment in Bridgebio Oncology Therapeut

Tip: Access up to 7 years of quarterly data

All positions including Bridgebio Oncology Therapeut held by Citigroup consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Bridgebio Oncology Therapeut by Citigroup

Quarter filed Position value Share count Share price at filing
2026-09-30 $45k 11k 4.10

More positions owned by Citigroup

NVIDIA Corporation (NVDA)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Ishares Tr Russell 2000 Etf (IWM)
Apple (AAPL)
Microsoft Corporation (MSFT)
Amazon (AMZN)
Meta Platforms Cl A (META)
Alphabet Cap Stk Cl A (GOOGL)
Tesla Motors (TSLA)
Broadcom (AVGO)
Micron Technology (MU)
Advanced Micro Devices (AMD)
Alphabet Cap Stk Cl C (GOOG)
Ishares Tr Iboxx Hi Yd Etf (HYG)
State Str Spdr S&p 500 Etf T Tr Unit (SPY)

View all positions for Citigroup

Top funds holding Bridgebio Oncology Therapeut

Cormorant Asset Management
Deerfield Management Company
Omega Fund Management
Alphabet
EcoR1 Capital
Wellington Management Company
Enavate Sciences GP
Citadel Advisors
Regents of the University of California
Novo A/S
BlackRock
Vanguard Capital Management
Laurion Capital Management
Armistice Capital
State Street Corporation

View all funds holding Bridgebio Oncology Therapeut